Website Under Maintenance

Newsroom Published Jun 08, 2024 01:50 PM

Our site is down for scheduled maintenance. We are working to update our network to better provide the page you requested. We understand the inconvenience this may cause, but rest assured, we are doing everything we can to bring the site back online after our necessary updates.

Korro Bio to Participate in 2022 Jefferies Healthcare Conference

By: Korro Bio, Inc. via Business Wire

June 06, 2022 at 16:45 PM EDT

Korro Bio, Inc., a leading RNA editing company focused on the discovery and development of novel genetic medicines, today announced that Ram Aiyar, Ph.D., MBA, Chief Executive Officer, will present at the 2022 Jefferies Healthcare Conference, being held in New York, NY, on Thursday, June 9, 2022, at 10:30 a.m. EDT.

About Korro Bio, Inc.

Korro is an RNA editing company focused on discovery and development of a new class of precision genetic medicines. Korro’s proprietary and modular platform, OPERA^TM, combines data-driven design with off-the-shelf chemistry and delivery to achieve highly selective RNA editing. This unique technology enables the functional benefits of gene therapy with a transient, repeated-administration regimen that permits pharmacologic titration of therapeutic efficacy and safety, in a cost-effective drug product. As a result, Korro’s portfolio of innovative RNA therapies have the potential to propel genetic medicine beyond rare genetic diseases into larger patient populations with common diseases. Korro is located in Cambridge, Mass. For more information, visit korrobio.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220606005971/en/

Contacts

Investors

Vineet Agarwal

vagarwal@korrobio.com

Media

Chris Railey

Ten Bridge Communications

chris@tenbridgecommunications.com

Website Under Maintenance

Website Under Maintenance

Korro Bio to Participate in 2022 Jefferies Healthcare Conference

Contacts

More News